Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Mariel Metcalfe
  • March 29, 2019
  • News

Research Partnership publishes new patient Living with Rheumatoid Arthritis (EU, Japan & Canada) 2019 reports

Research Partnership publishes new patient Living with Rheumatoid Arthritis (EU, Japan & Canada) 2019 reports

Living with Rheumatoid Arthritis is a report based on 416 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK), 51 patients in Japan and 107 patients in Canada. The study consists of 30-minute quantitative online and qualitative telephone interviews with patients. The qualitative interviews are enhanced with insights generated from pre-interview patient exercises – such as patient diary entries - to capture in-the-moment feelings about living with rheumatoid arthritis. These reports can be purchased as a package or individually.

read more »

  • Posted by Helen Parfitt, Mariel Metcalfe and Mark Hollis
  • March 22, 2019
  • Webinars

Navigating new frontiers: Ways to find space in the future RA market

Navigating new frontiers: Ways to find space in the future RA market

In partnership with pharmaphorum

Rheumatoid arthritis (RA) has been a major growth driver for the pharmaceutical industry over the last 15 years, led by AbbVie’s blockbuster anti-TNF inhibitor treatment Humira (adalimumab).

read more »

Infographic: Rheumatoid arthritis (RA)

Infographic: Rheumatoid arthritis (RA)

An overview of the RA biologic patient

Our RA market snapshot offers an introduction to the real world patient data collected by our Therapy Watch RA study. The snapshot looks at twelve of the key indices captured in Therapy Watch data.
 
 

read more »

  • Posted by Mariel Metcalfe
  • November 20, 2018
  • News

Research Partnership launches new patient Living with Rheumatoid Arthritis (EU & Japan) 2019 report

Research Partnership launches new patient Living with Rheumatoid Arthritis (EU & Japan) 2019 report

Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in the 5 EU markets (France, Germany, Italy, Spain, UK) and 55 patients in Japan. The report consists of 30-minute quantitative online and qualitative telephone interviews with patients. The qualitative interviews will be enhanced with insights generated from pre-interview patient exercises – such as patient diary entries - to capture in-the-moment feelings about living with rheumatoid arthritis. The report is an update on the existing Living with RA 2016 report and will be published in the 1st quarter of 2019.

read more »

  • Posted by Helen Parfitt
  • August 24, 2018
  • Articles

JAK inhibitors gaining traction for rheumatoid arthritis in EU5

JAK inhibitors gaining traction for rheumatoid arthritis in EU5

The new class of JAK inhibitor therapies is making a strong impression in the European market for rheumatoid arthritis (RA), according to recent prescribing data from specialist physicians.
Our latest Therapy Watch RA study, conducted in the key EU5 countries (France, Germany, Italy, Spain and the UK), found that in the dynamic segment of the RA market – defined as patients who have started or switched onto their current RA treatment in the three months preceding inclusion in the study – the orally -administered JAK inhibitors expanded their market share across the EU5 from 3.1% in the third quarter of 2017 to 15.6% in the second quarter of 2018.

read more »